Integrating obesity medicines in the national list of essential medicines: a policy concern.

The article discusses the need for comprehensive studies on the role of decreased pesticide stress markers and chromosomal aberration in resistant species of invertebrates in Kerala agroecosystems. It emphasizes the importance of understanding the evolution of pesticide-resistant pests and their ecological impacts through the use of genetic and biochemical/molecular biomarkers. The article also highlights the economic and social impact of pesticide resistance and the need for crop damage assessment. It concludes by suggesting the adoption of real-time information about pesticide resistance and its impacts on the ecosystem and local people in order to develop sustainable approaches to pest management and ensure food security.The text discusses the global rise in obesity rates, particularly in low- and middle-income countries. In India, data from the National Family Health Survey shows that the prevalence of obesity and abdominal obesity is significant. The text argues for the inclusion of obesity medications in the national list of essential medicines, citing evidence of their clinical efficacy and safety. However, the high cost of these medications is a major limitation for long-term use. The text suggests that the prices of obesity medications should be capped to make them more accessible. The inclusion of obesity medications is seen as important due to the interrelated conditions of metabolic syndrome and diabesity. [Extracted from the article]